
Inflammasomes and DED
The optimal management of dry eye disease (DED) often seems an enigma. A recently published collaborative review, by Ocular Surface Laboratory (OSL) and Buchanan Ocular Therapeutics Unit (BOTU) researchers at the University of Auckland, outlined current anti-inflammatory options used in clinical man










